956-p: efficacy and safety of oral semaglutide when added to basel, premix, or basel-bolus insulin
These complementary effects on fat and muscle catabolism suggest that GLP-1 RAs may help preserve skeletal muscle integrity while concurrently improving metabolic efficiency in the context of obesity-related muscle dysfunction
In the first week, I noticed my cravings after meals werent as strong, and my digestion felt calmer
Systemic manifestations potentially suggesting reduced efficacy may include: Unexplained loss of glycemic control in patients with type 2 diabetes, evidenced by rising hemoglobin A1c or fasting glucose levels Diminished appetite suppression or return of hunger despite continued treatment Weight loss plateau or weight regain without changes in diet or activity Reduced gastrointestinal effects that were previously present It's important to note that these systemic signs are non-specific and may reflect medication storage issues, injection technique problems, treatment adaptation, or disease progression rather than antibody formation
This can mean a nutritional supplement formulation that contains a high amount of glutathione might not yield the desired health outcome